These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

482 related items for PubMed ID: 2140831

  • 1. The ratios of serum bioactive/immunoreactive luteinizing hormone and follicle-stimulating hormone in various clinical conditions with increased and decreased gonadotropin secretion: reevaluation by a highly sensitive immunometric assay.
    Jaakkola T, Ding YQ, Kellokumpu-Lehtinen P, Valavaara R, Martikainen H, Tapanainen J, Rönnberg L, Huhtaniemi I.
    J Clin Endocrinol Metab; 1990 Jun; 70(6):1496-505. PubMed ID: 2140831
    [Abstract] [Full Text] [Related]

  • 2. Serum bioactive and immunoreactive follicle-stimulating hormone in prostatic cancer patients during gonadotropin-releasing hormone agonist treatment and after orchidectomy.
    Huhtaniemi IT, Dahl KD, Rannikko S, Hsueh AJ.
    J Clin Endocrinol Metab; 1988 Feb; 66(2):308-13. PubMed ID: 3123510
    [Abstract] [Full Text] [Related]

  • 3. Differing responses of plasma bioactive and immunoreactive follicle-stimulating hormone and luteinizing hormone to gonadotropin-releasing hormone antagonist and agonist treatments in postmenopausal women.
    Matikainen T, Ding YQ, Vergara M, Huhtaniemi I, Couzinet B, Schaison G.
    J Clin Endocrinol Metab; 1992 Sep; 75(3):820-5. PubMed ID: 1517372
    [Abstract] [Full Text] [Related]

  • 4. Response of circulating gonadotropin levels to GnRH agonist treatment in prostatic cancer.
    Huhtaniemi I, Venho P, Jacobi G, Rannikko S.
    J Androl; 1991 Sep; 12(1):46-53. PubMed ID: 1901309
    [Abstract] [Full Text] [Related]

  • 5. The effect of danazol and the LHRH agonist analogue goserelin (Zoladex) on the biological activity of luteinizing hormone in women with endometriosis.
    Maouris P, Dowsett M, Rose G, Edmonds DK, Rothwell C, Robertson WR.
    Clin Endocrinol (Oxf); 1990 Oct; 33(4):539-46. PubMed ID: 2146047
    [Abstract] [Full Text] [Related]

  • 6. Effects of oestrogen treatment on serum gonadotrophin bioactivity, immunoreactivity and isohormone distribution, and on immunoreactive inhibin levels, in prostatic cancer patients.
    Matikainen T, Haavisto AM, Permi J, de Kretser D, Huhtaniemi I.
    Clin Endocrinol (Oxf); 1994 Jun; 40(6):743-50. PubMed ID: 8033364
    [Abstract] [Full Text] [Related]

  • 7. Concordant suppression of serum immunoreactive luteinizing hormone (LH), follicle-stimulating hormone, alpha subunit, bioactive LH, and testosterone in postmenopausal women by a potent gonadotropin releasing hormone antagonist (detirelix).
    Andreyko JL, Monroe SE, Marshall LA, Fluker MR, Nerenberg CA, Jaffe RB.
    J Clin Endocrinol Metab; 1992 Feb; 74(2):399-405. PubMed ID: 1370507
    [Abstract] [Full Text] [Related]

  • 8. Low serum bioactive luteinizing hormone in nonorganic male impotence: possible relationship with altered gonadotropin-releasing hormone pulsatility.
    Fabbri A, Jannini EA, Ulisse S, Gnessi L, Moretti C, Frajese G, Isidori A.
    J Clin Endocrinol Metab; 1988 Nov; 67(5):867-75. PubMed ID: 3141450
    [Abstract] [Full Text] [Related]

  • 9. LH measurements by in vitro bioassay and a highly sensitive immunofluorometric assay improve the distinction between boys with constitutional delay of puberty and hypogonadotropic hypogonadism.
    Haavisto AM, Dunkel L, Pettersson K, Huhtaniemi I.
    Pediatr Res; 1990 Mar; 27(3):211-4. PubMed ID: 2181393
    [Abstract] [Full Text] [Related]

  • 10. Serum bioactive and immunoreactive luteinizing hormone and follicle-stimulating hormone levels in women with cycle abnormalities, with or without polycystic ovarian disease.
    Fauser BC, Pache TD, Lamberts SW, Hop WC, de Jong FH, Dahl KD.
    J Clin Endocrinol Metab; 1991 Oct; 73(4):811-7. PubMed ID: 1909705
    [Abstract] [Full Text] [Related]

  • 11. Hormonal effects of gonadotropin-releasing hormone (GnRH) agonist in the human male. III. Effects of long term combined treatment with GnRH agonist and androgen.
    Bhasin S, Heber D, Steiner BS, Handelsman DJ, Swerdloff RS.
    J Clin Endocrinol Metab; 1985 May; 60(5):998-1003. PubMed ID: 3920237
    [Abstract] [Full Text] [Related]

  • 12. The relationship between luteinizing hormone and estradiol secretion in female precocious puberty: evaluation by sensitive gonadotropin assays and the leuprolide stimulation test.
    Garibaldi LR, Aceto T, Weber C, Pang S.
    J Clin Endocrinol Metab; 1993 Apr; 76(4):851-6. PubMed ID: 8473395
    [Abstract] [Full Text] [Related]

  • 13. Differential regulation of serum immunoreactive luteinizing hormone and bioactive follicle-stimulating hormone by testosterone in early pubertal boys.
    Hassing JM, Padmanabhan V, Kelch RP, Brown MB, Olton PR, Sonstein JS, Foster CM, Beitins IZ.
    J Clin Endocrinol Metab; 1990 Apr; 70(4):1082-9. PubMed ID: 2108181
    [Abstract] [Full Text] [Related]

  • 14. Contrasts in the gonadotropin-releasing hormone dose-response relationships for luteinizing hormone, follicle-stimulating hormone and alpha-subunit release in young versus older men: appraisal with high-specificity immunoradiometric assay and deconvolution analysis.
    Zwart AD, Urban RJ, Odell WD, Veldhuis JD.
    Eur J Endocrinol; 1996 Oct; 135(4):399-406. PubMed ID: 8921820
    [Abstract] [Full Text] [Related]

  • 15. Serum luteinizing hormone (LH) biological activity in castrated patients with cancer of the prostate receiving a pure antiandrogen and in estrogen-pretreated patients treated with an LH-releasing hormone agonist and antiandrogen.
    St Arnaud R, Lachance R, Dupont A, Labrie F.
    J Clin Endocrinol Metab; 1986 Aug; 63(2):297-302. PubMed ID: 3522618
    [Abstract] [Full Text] [Related]

  • 16. Pituitary-testicular function of prostatic cancer patients during treatment with a gonadotropin-releasing hormone agonist analog. I. Circulating hormone levels.
    Huhtaniemi I, Nikula H, Rannikko S.
    J Androl; 1987 Aug; 8(6):355-62. PubMed ID: 3123445
    [Abstract] [Full Text] [Related]

  • 17. Pulsatile administration of gonadotropin-releasing hormone does not alter the follicle-stimulating hormone (FSH) isoform distribution pattern of pituitary or circulating FSH in nutritionally growth-restricted ovariectomized lambs.
    Hassing JM, Kletter GB, I'Anson H, Wood RI, Beitins IZ, Foster DL, Padmanabhan V.
    Endocrinology; 1993 Apr; 132(4):1527-36. PubMed ID: 8462450
    [Abstract] [Full Text] [Related]

  • 18. Maintenance of the ratio of bioactive to immunoreactive follicle-stimulating hormone in normal men during chronic luteinizing hormone-releasing hormone agonist administration.
    Pavlou SN, Dahl KD, Wakefield G, Rivier J, Vale W, Hsueh AJ, Lindner J.
    J Clin Endocrinol Metab; 1988 May; 66(5):1005-9. PubMed ID: 2834409
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.